New cancer clinical trial: Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE

Published on: September 17, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share